The current valuation score of Cronos Group Inc is 8.55, ranking 89 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -652.97, which is -109.30% below the recent high of 60.75 and -573.36% above the recent low of -4396.83.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.